{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:59:33Z","timestamp":1791118773031,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Mesenchymal stem cells (MSCs) are multi-potent non-hematopoietic progenitor cells possessing an immune-regulatory function, with suppression of proliferation of activated lymphocytes. In this study, adult living donor kidney transplantation (LDKT) recipients were given MSCs derived from the donor bone marrow to evaluate the safety and the feasibility of immunological changes related to the intra-osseous injection of MSC into the bone marrow.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>MSCs were derived from negative HLA cross-match donors. Donor bone marrow was harvested 5\u00a0weeks prior to KT. At the time of transplantation, 1 x 10<jats:sup>6<\/jats:sup> cell\/kg of donor MSC was directly injected into the bone marrow of the recipient\u2019s right iliac bone. Patients\u2019 clinical outcomes, presence of mixed chimerism by short tandem repeat polymerase chain reaction, analysis of plasma FoxP3 mRNA and cytokine level, and mixed lymphocyte reaction (MLR) were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Seven patients enrolled in this study and received donor MSC injections simultaneously with LDKT. The median age of recipients was 36\u00a0years (32\u2009~\u200948). The number of HLA mismatches was 3 or less in 5 and more than 3 in 2. No local complications or adverse events such as hypersensitivity occurred during or after the injection of donor MSC. There was no graft failure, but the biopsy-proven acute rejections were observed in 3 recipients during the follow-up period controlled well with steroid pulse therapy (SPT). The last serum creatinine was a median of 1.23\u00a0mg\/dL (0.83\u2009~\u20092.07). Mixed chimerism was not detected in the peripheral blood of the recipients at 1 and 8\u00a0week of post-transplantation. Donor-specific lymphocyte or T cell proliferation and Treg priming responses were observed in some patients. Plasma level of IL-10, a known mediator of MSC-induced immune suppression, increased in the patients with Treg induction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Donor MSC injection into the iliac bone at the time of KT was feasible and safe. A possible correlation was observed between the induction of inhibitory immune responses and the clinical outcome in the MSC-kidney transplanted patients. Further research will be performed to evaluate the efficacy of MSC injection for the induction of mixed chimerism and subsequent immune tolerance in KT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1479-5876-11-96","type":"journal-article","created":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T16:14:59Z","timestamp":1365696899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation; a pilot study"],"prefix":"10.1186","volume":"11","author":[{"given":"Hyunah","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Berm","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoung","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HyunSoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,11]]},"reference":[{"key":"1478_CR1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMra011295","volume":"346","author":"M Pascual","year":"2002","unstructured":"Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB: Strategies to improve long-term outcomes after renal transplantation. N Engl J Med. 2002, 346: 580-590. 10.1056\/NEJMra011295.","journal-title":"N Engl J Med"},{"key":"1478_CR2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","volume":"4","author":"HU Meier-Kriesche","year":"2004","unstructured":"Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004, 4: 378-383. 10.1111\/j.1600-6143.2004.00332.x.","journal-title":"Am J Transplant"},{"key":"1478_CR3","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1056\/NEJMoa020009","volume":"349","author":"BJ Nankivell","year":"2003","unstructured":"Nankivell BJ, Borrows RJ, Fung CL, O\u2019Connell PJ, Allen RD, Chapman JR: The natural history of chronic allograft nephropathy. N Engl J Med. 2003, 349: 2326-2333. 10.1056\/NEJMoa020009.","journal-title":"N Engl J Med"},{"key":"1478_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.yexcr.2003.11.016","volume":"294","author":"TJ Heino","year":"2004","unstructured":"Heino TJ, Hentunen TA, Vaananen HK: Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp Cell Res. 2004, 294: 458-468. 10.1016\/j.yexcr.2003.11.016.","journal-title":"Exp Cell Res"},{"key":"1478_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/oby.2003.11","volume":"11","author":"L Janderova","year":"2003","unstructured":"Janderova L, McNeil M, Murrell AN, Mynatt RL, Smith SR: Human mesenchymal stem cells as an in vitro model for human adipogenesis. Obes Res. 2003, 11: 65-74. 10.1038\/oby.2003.11.","journal-title":"Obes Res"},{"key":"1478_CR6","doi-asserted-by":"publisher","first-page":"20509","DOI":"10.1074\/jbc.M410148200","volume":"280","author":"D Davidson","year":"2005","unstructured":"Davidson D, Blanc A, Filion D, Wang H, Plut P, Pfeffer G, Buschmann MD, Henderson JE: Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Biol Chem. 2005, 280: 20509-20515. 10.1074\/jbc.M410148200.","journal-title":"J Biol Chem"},{"key":"1478_CR7","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005, 105: 1815-1822. 10.1182\/blood-2004-04-1559.","journal-title":"Blood"},{"key":"1478_CR8","doi-asserted-by":"publisher","first-page":"17384","DOI":"10.1073\/pnas.1103650108","volume":"108","author":"S Chiesa","year":"2011","unstructured":"Chiesa S, Morbelli S, Morando S, Massollo M, Marini C, Bertoni A, Frassoni F, Bartolome ST, Sambuceti G, Traggiai E, Uccelli A: Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc Natl Acad Sci USA. 2011, 108: 17384-17389. 10.1073\/pnas.1103650108.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1478_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3109\/08820139.2011.619022","volume":"41","author":"YS Choi","year":"2012","unstructured":"Choi YS, Jeong JA, Lim DS: Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect. Immunol Invest. 2012, 41: 214-229. 10.3109\/08820139.2011.619022.","journal-title":"Immunol Invest"},{"key":"1478_CR10","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Le Blanc","year":"2004","unstructured":"Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004, 363: 1439-1441. 10.1016\/S0140-6736(04)16104-7.","journal-title":"Lancet"},{"key":"1478_CR11","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Le Blanc","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringden O: Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008, 371: 1579-1586. 10.1016\/S0140-6736(08)60690-X.","journal-title":"Lancet"},{"key":"1478_CR12","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","volume":"81","author":"O Ringden","year":"2006","unstructured":"Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K: Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 2006, 81: 1390-1397. 10.1097\/01.tp.0000214462.63943.14.","journal-title":"Transplantation"},{"key":"1478_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2215\/CJN.04950610","volume":"6","author":"N Perico","year":"2011","unstructured":"Perico N, Casiraghi F, Introna M, Gotti E, Todeschini M, Cavinato RA, Capelli C, Rambaldi A, Cassis P, Rizzo P, Cortinovis M, Marasa M, Golay J, Noris M, Remuzzi G: Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin J Am Soc Nephrol. 2011, 6: 412-422. 10.2215\/CJN.04950610.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1478_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/jama.2012.316","volume":"307","author":"J Tan","year":"2012","unstructured":"Tan J, Wu W, Xu X, Liao L, Zheng F, Messinger S, Sun X, Chen J, Yang S, Cai J, Gao X, Pileggi A, Ricordi C: Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA. 2012, 307: 1169-1177. 10.1001\/jama.2012.316.","journal-title":"JAMA"},{"key":"1478_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006\/meth.2001.1262.","journal-title":"Methods"},{"key":"1478_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1600-6143.2006.01643.x","volume":"7","author":"S Itakura","year":"2007","unstructured":"Itakura S, Asari S, Rawson J, Ito T, Todorov I, Liu CP, Sasaki N, Kandeel F, Mullen Y: Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat. Am J Transplant. 2007, 7: 336-346. 10.1111\/j.1600-6143.2006.01643.x.","journal-title":"Am J Transplant"},{"key":"1478_CR17","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.tp.0000209919.90630.7b","volume":"81","author":"S Inoue","year":"2006","unstructured":"Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK, Dahlke MH: Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation. 2006, 81: 1589-1595. 10.1097\/01.tp.0000209919.90630.7b.","journal-title":"Transplantation"},{"key":"1478_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/TP.0b013e3181ea4240","volume":"90","author":"MJ Hoogduijn","year":"2010","unstructured":"Hoogduijn MJ, Popp FC, Grohnert A, Crop MJ, van Rhijn M, Rowshani AT, Eggenhofer E, Renner P, Reinders ME, Rabelink TJ, van der Laan LJ, Dor FJ, Ijzermans JN, Genever PG, Lange C, Durrbach A, Houtgraaf JH, Christ B, Seifert M, Shagidulin M, Donckier V, Deans R, Ringden O, Perico N, Remuzzi G, Bartholomew A, Schlitt HJ, Weimar W, Baan CC, Dahlke MH: Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). Transplantation. 2010, 90: 124-126.","journal-title":"Transplantation"},{"key":"1478_CR19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.exphem.2004.05.026","volume":"32","author":"S Castello","year":"2004","unstructured":"Castello S, Podesta M, Menditto VG, Ibatici A, Pitto A, Figari O, Scarpati D, Magrassi L, Bacigalupo A, Piaggio G, Frassoni F: Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol. 2004, 32: 782-787. 10.1016\/j.exphem.2004.05.026.","journal-title":"Exp Hematol"},{"key":"1478_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0897.2011.01069.x","volume":"67","author":"E Soleymaninejadian","year":"2012","unstructured":"Soleymaninejadian E, Pramanik K, Samadian E: Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol. 2012, 67: 1-8.","journal-title":"Am J Reprod Immunol"},{"key":"1478_CR21","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1097\/TP.0b013e3181fed001","volume":"90","author":"W Ge","year":"2010","unstructured":"Ge W, Jiang J, Arp J, Liu W, Garcia B, Wang H: Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation. 2010, 90: 1312-1320. 10.1097\/TP.0b013e3181fed001.","journal-title":"Transplantation"},{"key":"1478_CR22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2119\/molmed.2010.00098","volume":"17","author":"YH Kim","year":"2011","unstructured":"Kim YH, Wee YM, Choi MY, Lim DG, Kim SC, Han DJ: Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts. Mol Med. 2011, 17: 697-708.","journal-title":"Mol Med"},{"key":"1478_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3858\/emm.2009.41.5.035","volume":"41","author":"SH Yang","year":"2009","unstructured":"Yang SH, Park MJ, Yoon IH, Kim SY, Hong SH, Shin JY, Nam HY, Kim YH, Kim B, Park CG: Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. Exp Mol Med. 2009, 41: 315-324. 10.3858\/emm.2009.41.5.035.","journal-title":"Exp Mol Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-11-96.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:17:05Z","timestamp":1630538225000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-11-96"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,11]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1478"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-11-96","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,11]]},"assertion":[{"value":"12 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"96"}}